Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Prevention of Gout Flares During Allopurinol Initiation
NCT01451645Phase 4Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Oct 2011
- Primary completion
- Aug 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in gout, sponsored by Regeneron Pharmaceuticals. Started Oct 2011; status: completed.
02
Drugs
colchicine
03
Conditions
gout
Beyond the preview
Go deeper on NCT01451645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451645.